Minister calls for patient voice to be heard

5 May 2016

Patient power should be placed at the heart of a new relationship between the pharmaceutical industry and the National Health Service, UK life sciences minister George Freeman has said.

In a keynote address to more than 50 UK healthcare leaders, Mr Freeman called for an “effective and unambiguous working relationships between the companies developing new treatments and the clinicians who will make the decisions on using them”.

But he also stressed the importance of putting patient priorities at the top of the agenda. “The patient voice has to be at the heart of this and lead us into this new landscape,” he said.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK